We are live on
!
Find out more
ASP
Adams Street Partners Portfolio holdings
AUM
$260M
1-Year Est. Return
30.38%
This Fund
S&P 500
This Quarter
Est. Return
-16.71%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$471M
AUM Growth
-$195M
(-29%)
Cap. Flow
-$63.4M
Cap. Flow
% of AUM
-13.48%
Top 10 Holdings %
Top 10 Hldgs %
99.69%
Holding
25
New
8
Increased
–
Reduced
6
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
+$32.7M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$1.82M |
| 3 |
JD.com
JD
|
+$495K |
| 4 |
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
|
+$373K |
| 5 |
HubSpot
HUBS
|
+$309K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paylocity
PCTY
|
+$51M |
| 2 |
Q2 Holdings
QTWO
|
+$32.3M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$3.66M |
| 4 |
SALE
RetailMeNot, Inc. Series 1
SALE
|
+$3.62M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$2.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 83.02% |
| 2 | Healthcare | 13.45% |
| 3 | Financials | 0.16% |
| 4 | Consumer Discretionary | 0.1% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Paylocity
PCTY
$6.71B
| $211M | 44.9% |
7,830,320
-1,500,000
| -16% | -$51M |
|
|
2
Q2 Holdings
QTWO
$3.42B
| $152M | 32.24% |
6,821,548
-1,167,701
| -15% | -$32.3M |
|
|
OMED
3
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $27.6M | 5.86% |
1,663,650
| – | – |
|
4
FIVE9
FIVN
$1.77B
| $26.5M | 5.64% |
7,174,677
| – | – |
|
|
SRRA
5
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $17.8M | 3.79% |
+28,989
| New | +$32.7M |
|
|
CALL
6
DELISTED
magicJack VocalTec Ltd
CALL
| $17.6M | 3.74% |
1,976,861
| – | – |
|
|
SALE
7
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $13.2M | 2.8% |
1,600,422
-310,900
| -16% | -$3.62M |
|
|
ZAYO
8
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $1.72M | 0.36% |
+67,660
| New | +$1.82M |
|
|
ZNGA
9
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $849K | 0.18% |
372,160
| – | – |
|
|
HAPN
10
Happen Inc
HAPN
$2.08B
| $752K | 0.16% |
11,367
-28,766
| -72% | -$1.95M |
|
|
11
JD.com
JD
$40.8B
| $446K | 0.09% |
+17,101
| New | +$495K |
|
|
VTAE
12
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $386K | 0.08% |
+35,073
| New | +$373K |
|
|
13
HubSpot
HUBS
$10.5B
| $293K | 0.06% |
+6,317
| New | +$309K |
|
14
Atara Biotherapeutics
ATRA
$71.2M
| $146K | 0.03% |
+185
| New | +$226K |
|
|
TSRO
15
DELISTED
TESARO, Inc.
TSRO
| $125K | 0.03% |
3,119
-9,791
| -76% | -$535K |
|
|
PBPB
16
DELISTED
Potbelly
PBPB
| $48K | 0.01% |
+4,316
| New | +$51.8K |
|
|
MOBL
17
DELISTED
MobileIron, Inc.
MOBL
| $23K | ﹤0.01% |
+7,469
| New | +$34.4K |
|
18
Chegg
CHGG
$108M
| $15K | ﹤0.01% |
2,102
-1,333
| -39% | -$10.6K |
|
19
Antero Resources
AR
$10.9B
| – | – |
-32,406
| Closed | -$1.11M |
|
20
Inogen
INGN
$167M
| – | – |
-8,161
| Closed | -$364K |
|
|
ABMD
21
DELISTED
Abiomed Inc
ABMD
| – | – |
-32,281
| Closed | -$2.13M |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-41,610
| Closed | -$3.66M |
|
|
ZEN
23
DELISTED
ZENDESK INC
ZEN
| – | – |
-58,315
| Closed | -$1.29M |
|
|
CUDA
24
DELISTED
Barracuda Networks, Inc.
CUDA
| – | – |
-2,762
| Closed | -$109K |
|
|
CVT
25
DELISTED
CVENT, INC.
CVT
| – | – |
-50,956
| Closed | -$1.31M |
|
Similar funds
MA
LIM
WI
SHCM
BOC
LCM
ICM
HIA
Adams Street Partners's Q3 2015 Portfolio in Review
As of Q3 2015, Adams Street Partners held 25 positions worth $471M, down 29% from $665M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Adams Street Partners withdrew a net $63.4M in Q3 2015, closing 7 positions and reducing 6 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $3.66M position sold in full.
By sector, the portfolio is most concentrated in Technology at 83% of assets, down from 85% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adams Street Partners opened a new position in Sierra Oncology, Inc. Common Stock worth $17.8M.
- Adams Street Partners's largest Q3 2015 buy was Sierra Oncology, Inc. Common Stock: 28,989 shares worth $17.8M.
- Adams Street Partners's biggest Q3 2015 reduction was Paylocity, cutting an estimated $51M.
- Adams Street Partners fully exited Clovis Oncology, Inc. in Q3 2015, selling an estimated $3.66M.
- Adams Street Partners's ten largest holdings make up 100% of its $471M portfolio in Q3 2015.
- Adams Street Partners opened 8 new positions and closed 7 in Q3 2015.
- Adams Street Partners's portfolio value fell 29% quarter-over-quarter to $471M.
Based on Adams Street Partners's 13F filing for Q3 2015, filed 13 Nov 2015.